DHR vs INTC: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and Intel Corp. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Danaher Corporation ยท Healthcare
$221.12
+29.6% upside to fair value
Med Conviction Grade B High Quality
VS
Intel Corp. ยท Technology
$127.39
-8.4% upside to fair value
Low Conviction Grade D
QuantHub Verdict
DHR has more upside to fair value (+29.6%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric DHR INTC
Current Price $221.12 $127.39
Fair Value Estimate $286.52 $116.75
Upside to Fair Value +29.6% -8.4%
Market Cap $155.4B $642.6B
Forward P/E โ€” โ€”
EV / EBITDA 24.8x 185.2x
Price / Sales 6.2x 11.3x
Price / FCF 28.5x 229.7x
Revenue Growth YoY +5.5% +25.4%
Gross Margin 58.5% 38.9%
Operating Margin 20.4% 0.1%
Return on Equity 7.7% -10.8%
Dividend Yield 0.65% 0%
FCF Yield 3.51% 0.44%
Analyst Consensus Strong Buy Hold
Investment Thesis
DHR โ€” Danaher Corporation
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is highโ€ฆ
INTC โ€” Intel Corp.
Intel designs and manufactures CPUs, GPUs, networking silicon, and edge and data-center products across its Client Computing, Data Center and AI, and Intel Foundry segments, employing roughly 85,100 people under CEO Lip-Bu Tan. The business quality is currently low: TTM gross margin is 38.9%, TTM operating margin is 0.1%, TTM net margin is -19.8%, and ROE is -10.8%, so the company is not earning โ€ฆ
Accumulation Zones
Metric DHR INTC
Zone Low $214.89 $87.56
Zone High $243.54 $99.24
In Buy Zone? Yes No
โ† DHR Research    INTC Research โ†’    All Research